36 hours post BTCE treatment, we observed a near complete depletion of human CD117+AML PDX cells in the BM of CD117×CD3 BTCE-treated mice compared with control BTCE-treated mice (figure 6C). This evidence concerns the gene KIT and acute myeloid leukemia.